TG Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 3.73B 5.22B 2025-03
Alaunos Therapeutics USD -755000 395K 2024-12
Amgen USD 1.29B 1.02B 2025-03
Ardelyx USD 8.12M 5.89M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 311.2M 130.2M 2025-03
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
J&J USD 13.63B 9.74B 2025-03
Novartis USD 2.28B 1.34B 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



TG Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.